Recent Progress in the Application of Exosome Analysis in Ovarian Cancer Management

Author:

Keyvani Vahideh123,Ghale-Noie Zari Naderi1,Mollazadeh Samaneh4,Mahmoudian Reihaneh Alsadat356,Ghorbani Elnaz37,Naderi Hamid3,Khazaei Majid3,Hassanian Seyed Mahdi3,Ferns Gordon A.8,Avan Amir3910,Anvari Kazem6

Affiliation:

1. Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2. Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

3. Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

4. Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran

5. Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

6. Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

7. College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq

8. Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex, BN1 9PH, UK

9. Faculty of Health, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, 4059, Australia

10. College of Medicine and Health Sciences, National University of Science and Technology, Sultanate of Oman

Abstract

Abstract: Exosomes are very small (nano-sized) vesicles participating in tumor development by involvement in intercellular communication mediated by transferring biocomponents. Exosomes appear to play vital roles in various cancer development, such as ovarian cancer, a common malignancy in women. Several hallmarks of ovarian cancer are reported to be affected by the exosome-- mediated cellular cross-talk, including modulating peritoneal dissemination and chemoresistance. Since the expression of some biomolecules, such as miRNAs and mRNA, is changed in ovarian cancer, these exo-biomolecules can be applied as prognostic, diagnostic, and therapeutic biomarkers. Also, the selective loading of specific chemotherapeutic agents into exosomes highlights these biocarries as potential delivery devices. Exosomes could be artificially provided and engineered to better target the site of interest in ovarian cancer. In the present review, we summarize the notable achievement of exosome application in ovarian cancer management to gain applicable transitional insight against this cancer.

Publisher

Bentham Science Publishers Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3